There are inherent expectations of patients, health-care providers, and regulatory agencies for effective and safe injection drug products. This expectation requires that the quality, purity and quality of injected drugs be met. Unqualified injection products may result from inappropriate production processes, including the inadvertent use of inferior or incorrect APIs or excipients; manufacturing processes that pollute or adequately ensure asepsis; and packaging designs or inadequate quality. Ineffective quality control measures, whether sponsored by manufacturers or customers, may allow these defects not to be detected.
With more than 20 years of experience in the commercial production of aseptic injections, we provide a wide range of aseptic drug development and manufacturing capabilities on all scales, including liquid filling and freeze-dried vials. We also provide state-of-the-art commercial cGMP manufacturing for pre-loaded syringes and syringes. One-time (one-time) manufacturing technology and traditional stainless steel equipment available
Why Choose BOC Sciences?
Whatever your manufacturing requirements are, BOC Sciences will provide more to meet your expectations. Our aseptic capabilities also include process development and manufacture of biopharmaceuticals on a global commercial scale, from clinical to global commercial scale. With BOC Science as your single-source partner, you will be able to bring your findings to market with unprecedented speed and efficiency.